Elmo3 inhibitors are chemical compounds that specifically target and inhibit the function of engulfment and cell motility protein 3 (Elmo3), a member of the Elmo family of proteins involved in cellular processes such as cytoskeletal remodeling, cell migration, and phagocytosis. Elmo3 plays a critical role in the regulation of Rac1, a small GTPase that influences actin dynamics and is essential for the rearrangement of the cytoskeleton. Through its interaction with Dock family proteins, Elmo3 facilitates the activation of Rac1, enabling cells to undergo changes in shape, migrate, and engulf particles during processes such as immune responses and tissue development. By inhibiting Elmo3, these compounds block its ability to interact with signaling partners, thereby interfering with cell motility and cytoskeletal reorganization.
The use of Elmo3 inhibitors in research allows scientists to explore the mechanisms by which Elmo3 contributes to cellular migration and engulfment processes. By inhibiting Elmo3, researchers can investigate how changes in Rac1 activation and actin dynamics affect various cellular behaviors, such as movement, cell shape changes, and interaction with the surrounding environment. These inhibitors provide insights into the molecular pathways that control cell migration, enabling the study of how cells navigate through tissues during development, wound healing, or immune surveillance. Elmo3 inhibitors also shed light on the specific role of this protein in the broader context of cytoskeletal regulation, making them valuable tools for understanding the coordination of cellular processes that depend on precise cytoskeletal control and signaling pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and inflammation. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Proton pump inhibitor that blocks gastric acid secretion by inhibiting H+/K+ ATPase in stomach lining cells. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Tyrosine kinase inhibitor targeting BCR-ABL, inhibiting signaling in chronic myeloid leukemia. | ||||||
Donepezil | 120014-06-4 | sc-279006 | 10 mg | $74.00 | 3 | |
Acetylcholinesterase inhibitor that increases acetylcholine levels, used in Alzheimer's disease. | ||||||
Ritonavir | 155213-67-5 | sc-208310 | 10 mg | $124.00 | 7 | |
HIV protease inhibitor disrupting viral replication by inhibiting cleavage of viral polyproteins. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Folate antagonist inhibiting dihydrofolate reductase, impeding DNA synthesis in cancer cells. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
Xanthine oxidase inhibitor reducing uric acid production. | ||||||
Warfarin | 81-81-2 | sc-205888 sc-205888A | 1 g 10 g | $73.00 $246.00 | 7 | |
Vitamin K antagonist that inhibits clotting factors II, VII, IX, and X, preventing blood clot formation. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multi-kinase inhibitor targeting RAF, VEGFR, and PDGFR, studied in the research of kidney cancer. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Selective estrogen receptor modulator (SERM) blocking estrogen binding in breast cancer therapy. | ||||||